SCHEMBL6283905

SCHEMBL6283905

CCCCCN1C(=O)C(=O)c2cccc(-c3ccccc3)c21

nearest known ligand 0.62

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.62
ALDH2 P05091 1/20 0.62
ALDH3A1 P30838 1/20 0.62
CDC25A P30304 6/20 0.61
CES1 P23141 2/20 0.61
MAPT P10636 3/20 0.52
HPGD P15428 2/20 0.52
L3MBTL1 Q9Y468 2/20 0.49
ALOX15 P16050 1/20 0.49
TSHR P16473 1/20 0.49
ALOX12 P18054 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
HSD17B10 Q99714 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
MEN1 O00255 1/20 0.47
LMNA P02545 1/20 0.47
MAPK1 P28482 1/20 0.47
KMT2A Q03164 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6286098 0.99 CDC25A (0.63) ALDH1A1ALDH2ALDH3A1CDC25ACES1
SCHEMBL6281435 0.99 CDC25A (0.63) ALDH1A1ALDH2ALDH3A1CDC25ACES1
SCHEMBL6283021 0.99 CDC25A (0.63) ALDH1A1ALDH2ALDH3A1CDC25ACES1
SCHEMBL6280422 0.99 CDC25A (0.63) ALDH1A1ALDH2ALDH3A1CDC25ACES1
SCHEMBL6279195 0.99 CDC25A (0.63) ALDH1A1ALDH2ALDH3A1CDC25ACES1
SCHEMBL6284050 0.99 CDC25A (0.63) ALDH1A1ALDH2ALDH3A1CDC25ACES1
SCHEMBL6286569 0.99 CDC25A (0.63) ALDH1A1ALDH2ALDH3A1CDC25ACES1
SCHEMBL6283990 0.96 ALDH1A1 (0.56) ALDH1A1ALDH2ALDH3A1CDC25ACES1
SCHEMBL5424141 0.88 ALDH1A1 (0.55) ALDH1A1ALDH2ALDH3A1CDC25ACES1
SCHEMBL6283127 0.86 ALDH1A1 (0.49) ALDH1A1ALDH2ALDH3A1CDC25ACES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6906090-B1 Compositions and methods for treating mycobacterial diseases ASTRAZENECA AB (SE) 2005-06-14 US claimed
EP-1058548-B1 THE USE OF ISATIN AND OXINDOLE DERIVATIVES IN THE PREPARATION OF A MEDICAMENT FOR USE IN THE TREATMENT OF MYCOBACTERIAL DISEASE ASTRAZENECA AB (SE) 2003-09-17 EP claimed
EP-1058548-A1 NEW USE AstraZeneca AB (SE) 2000-12-13 EP claimed
WO-1999044608-A1 NEW USE ASTRAZENECA AB (SE) 1999-09-10 WO claimed
US-6906090-B1 Compositions and methods for treating mycobacterial diseases ASTRAZENECA AB (SE) 2005-06-14 US disclosed
EP-1058548-B1 THE USE OF ISATIN AND OXINDOLE DERIVATIVES IN THE PREPARATION OF A MEDICAMENT FOR USE IN THE TREATMENT OF MYCOBACTERIAL DISEASE ASTRAZENECA AB (SE) 2003-09-17 EP disclosed
EP-1058548-A1 NEW USE AstraZeneca AB (SE) 2000-12-13 EP disclosed
WO-1999044608-A1 NEW USE ASTRAZENECA AB (SE) 1999-09-10 WO disclosed